The long-term effect of botulinum neurotoxin A (BoNT-A) on children with cerebral palsy
(CP) is unclear, and how the dynamic changes of metabolites impact the duration of effect …

Introduction Botulinum neurotoxin-A (BoNT-A) is an accepted treatment modality for the
management of hypertonia in children and young people with cerebral palsy (CYPwCP) …

Botulinum toxin type A (BoNT-A) injections in children with cerebral palsy (CP) may
negatively affect muscle growth and strength. We injected BoNT-A into the affected limbs of …

Cerebral palsy (CP) is a non-progressive motor condition that hinders the development of
movement and posture. One of the common problems faced in CP is spastic hips, which can …

В статье приводятся исторические данные об открытии действия ботулотоксина и его
внедрении в неврологическую практику. Рассмотрен механизм действия …

Multani et al.'s [1] recent paper titled “Botulinum Toxin in the Management of Children with
Cerebral Palsy” implies it is a comprehensive, evidence-based discussion of all aspects of …

Background Functional mobility in children with cerebral palsy (CP) varies widely and is
affected by many factors related to the child and environment. Understanding this variability …

Retrospective analytical study that aims to evaluate the kinematic and kinetic results
obtained after percutaneous lengthening with an intramuscular needle (PLIN) of …

Spasticity is the most common motor disturbance in cerebral palsy (CP). Lockdown in the
COVID-19 outbreak has profoundly changed daily routines, and similarly caused the …

刘国庆, 钟镇, 江伟, 陈玉霞, 肖农△(重庆医科大学附属儿童医院康复科/儿童发育疾病研究教育部
重点实验室/国家儿童健康与疾病临床医学研究中心/儿童发育重大疾病国家国际科技合作基地 …